...
机译:低T3综合征作为慢性淋巴细胞白血病预后不良的预测因子
Department of Endocrinologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Hematologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Hematologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Hematologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Hematologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Hematologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Hematologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Hematologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Hematologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Endocrinologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
Department of Hematologythe First Affiliated Hospital of Nanjing Medical University Jiangsu;
low T3 syndrome; chronic lymphocytic leukemia; prognosis;
机译:低T3综合征作为慢性淋巴细胞白血病预后不良的预测因子
机译:Ofatumumab在预后不良的慢性淋巴细胞性白血病中的作用:来自欧洲慢性淋巴细胞性白血病研究计划的IV期非干预性观察性研究|血液学
机译:TP53诱导的糖酵解和凋亡调节剂可防止自发凋亡并预测慢性淋巴细胞白血病的预后不良
机译:使用机器学习生存率和分类方法预测慢性淋巴细胞白血病首次治疗的时间
机译:低密度脂蛋白对慢性淋巴细胞性白血病进展的影响。
机译:Ofatumumab在预后不良的慢性淋巴细胞性白血病中的作用:一项来自欧洲慢性淋巴细胞性白血病研究计划的IV期非干预性观察性研究
机译:Ofatumumab在预后不良的慢性淋巴细胞性白血病中的作用:一项来自欧洲慢性淋巴细胞性白血病研究计划的4期非干预性观察性研究